SEC Form 4 · accession 0001093557-17-000189
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Doubleday
Officer — EVP, Chief Commercial Officer
Period of report
Sep 11, 2017
Accepted (ET)
Sep 13, 2017 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 11, 2017 | D | 3,347 | $71.8134 | D | 69,233 | D | |
| Common StockF1,F2 | Sep 11, 2017 | D | 4,184 | $71.8134 | D | 65,049 | D | |
| Common StockF3 | holding | — | — | — | 23,785 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- F2Included in this number are 54,427 unvested restricted stock units, 27,510 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 19,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 7,917 of which were granted on March 8, 2015 and shall vest through March 8, 2018.
- F3Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.